TrialPloS one2011

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

Punnee Pitisuttithum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.